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ABSTRACT 
The value-added use of peach stone for production of a high protein product was 
investigated. Different parameters were optimized in order to obtain the highest protein 
yield in the extraction of peach seed proteins. Optimal conditions enabled the extraction of 
43 g of protein per 100 g of dried and defatted milled seeds. Different enzymes and 
parameters were also tried in order to obtain the highest hydrolysis degree in the digestion 
of this peach seed protein isolate. Thermolysin was the enzyme that yielded the extract with 
the highest ACE-inhibition capability. After ultrafiltration through different molecular 
weight cut-off filters, potential antihypertensive peptides remained in the fraction below 3 
kDa. Three different peptides (LYSPH, LYTPH, and HLLP) resisting simulated 
gastrointestinal digestion and ACE activity and demonstrating antihypertensive in vitro 
capacity were identified by HPLC-MS/MS. This is the first time that potential 
antihypertensive peptides have been isolated from peach stones. 
 
Keywords: peach, seed, peptides, ACE-inhibitor, de novo sequencing. 
1. Introduction 
 There is a great concern on recycling of residues generated in the processing of 
foods. Despite several attempts for their reuse, these byproducts are mainly sent to landfills 
or are incinerated (Restrepo Gallego, 2006). The search for new recovery strategies and the 
revalorization of these wastes are priority items in developing countries (Arvanitoyannis & 
Varzakas, 2008; Piotrowska, Zevenhoven, Hupa, Giuntoli, & de Jong, 2013).  
 Peach is a seasonal fruit belonging to the genus Prunus. In addition to its fresh 
consumption, large amounts of peaches are intended to produce juices, marmalades, and 
canned peaches, among others. Processing of peach is a source of waste material mainly 
made up of stones and skins. Peach stone contains a seed inside with a high protein content 
that has not usually been reused and characterized (Pelentir, Block, Monteiro Fritz, 
Regginatto & Amante, 2011; Lima, Lima, Tavares, Costa, & Pierucci, 2014). Therefore, 
peach seeds could constitute a cheap source of proteins and peptides.  
Food derived bioactive peptides can be defined as specific protein fragments that 
have a positive impact on body functions or conditions and may ultimately influence health 
(Kitts & Weiler, 2003). Proteins are recognized as rich sources of bioactive peptides. 
Bioactive peptides can be within the sequence of proteins in an inactive state and exert 
physiological actions after their release (Puchalska, Marina, & García, 2015). The release 
of peptides can be carried out by in vitro enzymatic hydrolysis. Different beneficial health 
effects have been described within bioactive peptides being angiotensin I converting 
enzyme (ACE) inhibitors of special interest since they are useful for the regulation of 
hypertension (Hartmann & Meisel, 2007; Korhonen & Pihlanto, 2006; Shahidi & Zhong, 
2008; García, Puchalska, Esteve, & Marina, 2013). 
Hypertension affects about a quarter of world’s population and is a major risk factor 
involved in cardiovascular diseases (World Health Organization, 2013). The renin-
angiotensin system is the main regulator of blood pression in human organism. In this 
system, ACE converts the decapeptide angiotensin I into the vasoconstrictor peptide 
angiotensin II and, at the same time, deactivates the vasodilator bradykinin (Struthers & 
McDonald, 2004). Therefore, this enzyme plays a significant role in the control of blood 
pressure. Consequently, synthetic antihypertensive drugs with capacity to inhibit ACE 
activity have been mostly used (Bezalel, Mahlab-Guri, Asher, Werner, Sthoeger, & 2015). 
Although synthetic drugs exhibit high capability to inhibit ACE, they can cause various 
side effects (Bezalel et al., 2015). Natural antihypertensive peptides are effective blood 
pressure reducers and, unlike synthetic drugs, they do not exert side effects. ACE-inhibitory 
peptides are small peptides (2-12 amino acids) with high level of hydrophobic amino acids 
and, commonly, with proline at C-terminal (Puchalska et al., 2015).  
 Different strategies based on the extraction of bioactive peptides from food 
byproducts have previously been developed (García, Orellana, & Marina, 2015). Most of 
these works have been devoted to fish and seafood byproducts and very few contributions 
were focused on fruit seeds (García et al. 2015). The aim of this work was to purpose, for 
the first time, the revalorization of peach stones based on the extraction of peptides with 
ACE-inhibition capacity.  
2. Materials and methods  
2.1. Chemical and samples 
All reagents were of analytical grade and HPLC-grade water was daily obtained with a 
Milli-Q system from Millipore (Bedford, MA, USA). Tris(hydroxymethyl)aminomethane 
(Tris), hydrochloric acid, sodium phosphate, and sodium dodecyl sulphate (SDS) were 
from Merck (Darmstadt, Germany). Ammonium bicarbonate, sodium hydroxide, 
dithiothreitol (DTT), o-phthaldialdehyde (OPA), methanol (MeOH), sodium tetraborate, 2-
mercaptoethanol (2-ME), glutathione (GSH), acetic acid (AA), N-(2-hydroxyethyl)-1-
piperazinyl-N’-(2-ethanesulphonic) acid (HEPES), tripeptide hippuryl-histidyl-leucine 
(HHL), trifluorocetic acid (TFA), and angiotensin converting enzyme (ACE) from rabbit 
lung were from Sigma-Aldrich (St. Louis, MO, USA). Acetonitrile HPLC-grade (ACN), 
acetone, and hexane were purchased at Scharlau Chemie (Barcelona, Spain). Laemmli 
buffer, Tris/glycine/SDS running buffer, Mini-Protean® Precast gels, Bio-Safe Coomassie 
stain CBB G-250, Precision Plus Protein Standards (recombinant proteins expressed by E. 
Coli with molecular weights from 10 to 250 kDa), and Bradford reagent Coomassie blue G-
250 were obtained from Bio-Rad (Hercules, CA, USA). Thermolysin enzyme, bovine 
serum albumin (BSA), and pepsin and pancreatin digestive enzymes were from Sigma-
Aldrich. Alcalase 2.4 L FG and Flavourzyme 1000 L were generously donated by 
Novozymes Spain S.A (Madrid, Spain) while Protease P was thankfully donated by Amano 
Enzyme Inc. (Nagoya, Japan). Peaches were purchased in a local market (Alcalá de 
Henares, Madrid, Spain).  
 
 
2.2. Protein extraction 
Peaches were manually pitted. Peach seeds were obtained from the stone using a 
nutcracker and stored at -20 °C until use. Seeds were ground with a domestic mill and 
moisture was determined keeping milled seeds at 103 ± 2 °C until constant weight. 
Ground seeds (0.5 g) were defatted with hexane (25 mL) by vigorous shaking for 30 
min, this process was repeated 3 times with cleaned hexane. Final optimized conditions for 
the extraction of proteins from peach seeds were: A 5 mL of extraction buffer (100 mM 
Tris-HCl (pH 7.5), 0.5 % (w/v) SDS, and 0.5 % (w/v) DTT) were added to 30 mg of 
defatted peach seeds. A high intensity focused ultrasound (HIFU) probe from Sonic Vibra-
Cell (model VCX 130, Hartford, CT, USA) was employed during 1 min at 30 % of 
amplitude to accelerate protein extraction. After centrifugation at 4000 g for 10 min, the 
supernatant was collected, added to 10 mL of cold acetone, and kept in the fridge for 15 
min for protein precipitation. The pellet resulting after centrifugation (4000 g for 10 min) 
was mixed with 100 mM Tris-HCl (pH 7.5) and 0.5 % (w/v) of SDS until complete 
solution. The obtained mixture was filtered with regenerated cellulose filters of 0.45 µm. 
Protein concentration was estimated by Bradford colorimetric assay (Bradford, 1976). 
2.3. SDS-PAGE separation of proteins 
A Bio-Rad Mini-Protean system was employed for the separation of proteins by SDS-
polyacrylamide gel electrophoresis (PAGE). Laemmli buffer consisted of 62.5 mM Tris-
HCl (pH 6.8), 25 % (v/v) glycerol, 2 % (w/v) SDS, 0.01 % bromophenol blue, and 5 % 
(v/v) 2-ME. Samples were prepared at denaturing conditions by mixing 15 µL of protein 
sample with 15 µL of Laemmli buffer and heating at 100 °C for 5 min. The Mini-Protean 
cell was loaded with the running buffer (25 mM Tris-HCl (pH 8.3), 192 mM glycine, and 
0.1 % (w/v) SDS) and gels were loaded with 30 µL of protein sample or protein standard 
solution. Separation was carried out by application of 80 V for 15 min and 200 V for 40 
min. After separation, proteins were fixed with 50 mL of 40 % (v/v) MeOH and 10 % (v/v) 
AA by shaking for 30 min and stained with 50 mL of Bio-Safe Coomasie Blue by shaking 
for 1 h. Finally, gels were rinsed with Milli-Q water for 2 h or overnight. Gels were 
scanned in a home scanner Hewlett Packard PSC 1510 (Palo Alto, CA, USA). 
2.4. RP-HPLC separation of proteins 
A liquid chromatography equipment 1100 series from Agilent Technologies 
(Pittsburgh, PA, USA) was employed. It was equipped with a vacuum degasser system, a 
quaternary pump, an automatic injection system, a column thermostatic compartment, a 
diode array detector, and a fluorescence detector. Data acquisition was performed by the 
HP-Chemstation software. ARP perfusion POROS R2/10 (100 x 2.1 mm) column from 
Perseptive Biosystems (Framingham, MA, USA) was employed. The mobile phases 
consisted of 0.1 % (v/v) TFA in water (mobile phase A) and 0.1 % (v/v) TFA in ACN 
(mobile phase B). The elution gradient was 30-45 % B in 20 min, the flow rate was 0.5 
mL/min, the column temperature was 60 °C, and the injection volume was 20 µL. UV 
detection at 210, 254, and 280 nm and florescence detection at excitation and emission 
wavelengths of 280 and 360 nm, respectively, were employed.  
2.5. Protein digestion 
Four different enzymes were used: Alcalase, Thermolysin, Flavourzyme, and Protease 
P. Isolated peach seed proteins were dissolved in the corresponding digestion buffer 
(phosphate buffer (PB) at pH 8 for Alcalase and Thermolysin, PB at pH 7.5 for Protease P, 
and ammonium bicarbonate buffer (ABB) at pH 6.5 for Flavourzyme) and after addition of 
the enzyme, they were incubated in a Thermomixer Compact (Eppendorf, Hamburg, 
German) at 50 ºC (for Alcalase, Flavourzyme, and Thermolysin) or 40 ºC (for Protease P) 
with shaking at 600 rpm. The digestion was stopped by increasing the temperature to 100 
°C for 10 min. After centrifugation (4500 g for 5 min), the supernatant was collected and 
the degree of hydrolysis (% DH) and ACE-inhibitory capacity were evaluated. Enzyme 
autolysis blanks in absence of sample were also measured. 
Fractionation of peptides by ultrafiltration was carried out by using molecular weight 
cut-off (MWCO) filters Amicon® Ultra of 5 kDa and 3 kDa from Merck Millipore 
(Tullagreen, Ireland). 
2.6. Determination of the degree of hydrolysis (DH) 
The DH was evaluated according to the method described by Wang et al. (2008) with 
some modifications. A 40 mg/mL solution of OPA reagent in MeOH was employed to 
prepare a fresh 5 mL mixture consisting of 2.5 mL of 100 mM sodium tetraborate, 1mL of 
5 % (v/v) SDS, 1.39 mL of water, 10 µL of 2-ME, and 100 µL of previous OPA solution. 
Next, 2.5 µL of sample was incubated with 100 µL of that mixture for 8 min at room 
temperature and the absorbance corresponding to the compounds formed by the reaction of 
OPA reagent with α-amino groups of peptides was measured at 340 nm using a 
spectrophotometer Lambda 35 from Perkin-Elmer (Walthman, MA, USA). The peptide 
content was calculated by interpolation in a calibration curve obtained when using the 
tripeptide GSH (0-5 mg/mL) as standard. The DH (%) was estimated following the 
equation below, where the protein content was obtained by Bradford assay:  
    
2.7. In vitro evaluation of ACE-inhibitory capacity 
The ACE-inhibitory capacity was evaluated following the method described by Geng, 
He, Yang, and Wang (2010) with some modifications. The IC50 value (peptide 
concentration needed for the inhibition of 50 % ACE activity) was employed in order to 
express the in vitro effectiveness of ACE-inhibitory peptides. The method was based on the 
conversion of the tripeptide HHL into hippuric acid (HA), catalyzed by ACE. The 
capability of peptides to inhibit ACE was monitored by measuring the signal corresponding 
to HA. 
The ACE-inhibition assay was carried out by mixing 10 µL of ACE solution (0.05 
U/mL) with 5 µL of 1.3 mg/mL of HHL (diluted in 50 mM HEPES (pH 8.3) with 300 mM 
NaCl), 17.5 µL of 50 mM HEPES, and 2.5 µL of sample. After 3 h incubation at 37 °C, the 
reaction was stopped by the addition of 50 µL of cold ACN. The samples were next 
separated by HPLC using a RP column C-18 Chromolith® Performance, 100 x 4.6 mm 
form Merck (Darmstat, Germany). Chromatographic conditions were: mobile phases, 0.025 
% (v/v) TFA in water (mobile phase A) and 0.025 % (v/v) TFA in ACN (mobile phase B);  
gradient, 5-95 % B in 10 min; flow rate, 1 mL/min; temperature, 25 °C; and injection 
volume, 10 µL; detection at 228 nm. ACE inhibition (%) was determined using the 
following equation: 
   
where  is the peak area of HA in absence of ACE inhibition and  is the 
peak area of HA with sample. In order to evaluate the IC50 value, six dilutions of every 
sample were measured and ACE inhibition (%) values were plotted vs peptide 
concentration. IC50 value was determined by interpolation at the 50% of ACE inhibition in 
that graph. In all cases, IC50 was evaluated using two independent sample solutions that 
were measured, at least, two times. 
2.8. Resistance to simulated gastrointestinal digestion and ACE 
The in vitro gastrointestinal digestion (GID) was carried out according to the method of 
Garrett, Failla, & Sarama (1999) with slight modifications. Briefly, the pH of hydrolyzates 
was adjusted with 1 M HCl to pH 2 followed by digestion with pepsin enzyme (1:35, 
enzyme: substrate ratio) at 37 °C with shaking for 1 h. Afterwards, the pH was adjusted to 
pH 5 with 0.1 M NaHCO3 and to pH 7-8 with 0.1 M NaOH and pancreatin enzyme 
(mixture of pancreatic proteases) was added at a 1:25 (w/w) enzyme to substrate ratio. The 
mixture was incubated by shaking at 37 °C and after 3 h digestion, the digestion was 
stopped by heating at 95 °C for 15 min.  
The resistance of peptides to ACE was evaluated using the method reported by Fujita, 
Yokoyama, and Yoshikawa (2000) with some modifications. A peptide solution of 2 
mg/mL in 0.1 M PB (pH 8.3) containing 0.3 M NaCl was incubated with ACE (3 mU 




2.9. Identification of ACE-inhibitory peptides by HILIC- and RP-HPLC-ESI-Q-ToF 
A Quadrupole-Time-of-Flight (Q-TOF) mass spectrometer (Series 6530) coupled to a 
liquid chromatograph (model 1100), both from Agilent Technologies was employed. For 
the RP-HPLC separation of peptides, an Ascentis Express Peptide ES-C18 column (100 
mm x 2.1 mm I.D., 2.7 µm particle size) with its corresponding guard column (5 mm x 2.1 
mm, 2.7 µm particle size) from Supelco (Bellefonte, PA, USA) were used. For the HILIC 
separation of peptides, an Ascentis Express column (100 mm x 2.1 mm I.D., 2.7 µm 
particle size) with its corresponding guard column (5 mm x 2.1 mm, 2.7 µm particle size), 
also from Supelco, were employed. Chromatographic conditions for the RP-HPLC 
separation were: mobile phases, 0.3% (v/v) AA in water (mobile phase A) and 0.3 % (v/v) 
AA in ACN (mobile phase B); gradient, 3-35 % B in 30 min. Chromatographic conditions 
for the HILIC separation were: 65 mM ammonium acetate in ACN (mobile phase A) and 
65 mM ammonium acetate in water (mobile phase B); gradient, 60-95 % B in 30 min. 
Other common chromatographic conditions were: flow rate, 0.3 mL/min; column 
temperature, 25 °C; injection volume, 10 µL.  
Mass spectrometry (MS) detection was carried out in the positive ion mode using a 
scanning range from 100 to 1500 m/z. ESI Jet Stream source conditions were: sheath gas 
temperature, 400 °C; sheath gas flow, 12 L/min; drying gas flow, 12 L/min; drying gas 
temperature, 350 °C; nebulizer pressure, 50 psig; fragmentator voltage, 200 V; capillary 
voltage, 500 V. Tandem MS was performed using the Auto (MS/MS) mode and collision 
induced dissociation was set at 4 V per each 100 Da. De novo sequencing of peptides was 
carried out with PEAKS Studio 7 software from Bioinformatic Solutions Inc. (Waterloo, 
ON, Canada). Identified peptides showed an average local confidence (ALC, expected 
percentage of correct amino acids in the peptide sequence) equal or superior to 90% and a 
good precursor fragmentation pattern. Identifications were carried out using two 
independent samples injected by duplicate. Since it is not possible to differentiate I from L 
by MS due to their equal molecular masses, only isoforms with L were presented in our 
results, although peptide sequences containing I amino acid instead of L are also possible. 
2.9 Statistical analysis 
All data were presented by means and ± standard deviation (SD). So, in order to find 
statistically significant differences among the highest ACE-inhibitory extracts before and 
after gastrointestinal digestion, the comparison of two means was performed by Student’s t-
test to two replicates measured by duplicate at least. For that purpose, the statistical analysis 
was performed using Statgraphics Software Plus 5.1 (Statpoint Technologies, Inc., 
Warrenton, VA).  
3. Results and discussion 
3.1. Extraction of proteins from peach seeds 
Since there is no method enabling the extraction of proteins from peach seeds, a method 
previously reported by our research group and used to extract proteins from olive seeds was 
firstly tried (Esteve, Del Río, Marina & García, 2010). Briefly, the method involved an 
extraction with 125 mM of Tris-HCl buffer (pH 7.5) containing 1 % (w/v) SDS and 0.5 % 
(w/v) DTT using HIFU for 5 min at 30 % of amplitude and followed by cold acetone 
precipitation of proteins for 1 h. Under these conditions, it was possible to extract 16.8 g ± 
2.3 g of proteins per 100 g of raw seeds. Moreover, extracted proteins were separated by 
SDS-PAGE (see Figure 1) and RP-HPLC (see Figure 2A) observing 6 main bands by SDS-
PAGE and more than 11 chromatographic peaks pertaining to proteins. 
In order to assure that all peach seed proteins have been extracted, different extraction 
parameters were next optimized (extracting buffer composition, HIFU probe time and 
amplitude, and protein precipitation time). Moreover, in order to avoid an upper lipidic 
layer appearing in the extracts and interfering in the extraction of proteins, a previous lipid 
extraction step was proposed. The extraction of peach seeds with hexane for 30 min (three 








Figure 1. Electrophoretic separation of peach seed proteins under initial (125 mM Tris-HCl (pH 
7.5) with 1 % (w/v) SDS and 0.5 % (w/v) DTT as extracting buffer using HIFU for 5 min at 30 % 
of amplitude and protein precipitation with cold acetone for 1 h) and optimal (100 mM Tris-HCl 
(pH 7.5) with 0.5 % (w/v) SDS and 0.5 % (w/v) DTT) as extracting buffer using HIFU for 1 min at 








Figure 2. RP-HPLC separation of peach seed proteins using different extraction buffers (A) and 
different concentrations of Tris-HCl buffer (B). Chromatographic conditions: Perfusion column 
(100 x 2.1 mm); gradient: 30-45% B in 20 min; mobile phases: water + 0.1 % (v/v) TFA (mobile 
phase A) and AcN + 0.1 % (v/v) TFA (mobile phase B); flow-rate, 0.5 mL/min; temperature, 60 ºC; 
injected volume, 20 μL; fluorescence detection at a λEXC of 280 nm and λEM of 360 nm. 
Different extraction buffers (125 mM of Tris-HCl buffer at pHs 7.5, 8.0, 8.5, 9.0 and 
125 mM of PB at pHs 6.5, 7.0, and 7.5) were tried. Figure 2A shows how the type of buffer 
and pH affected the number and resolution of chromatographic peaks. Moreover, the total 
peak area was also calculated observing that the Tris-HCl buffer (pH 7.5) seemed to be the 
best option for the extraction of peach seed proteins. Furthermore, different Tris-HCl buffer 
(pH 7.5) concentrations (20, 50, 100, and 125 mM) were also tried (see Figure 2B) 
observing a higher number of peaks and a higher protein extraction at buffer concentrations 
from 100 mM. Additionally, SDS and DTT at different concentrations (0.0, 0.5, 1.0, 1.5, 
and 2.0 % (w/v) for SDS and 0.0, 0.25, 0.5, and 1.0 % (w/v) for DTT) were also tested. 
Both reagents favor protein denaturation by disrupting interactions within proteins, between 
proteins, and between metabolites and proteins (Wu, Gong, & Wang, 2014). As expected, 
the presence of both reagents improved protein extraction although no significant variation 
in the number of peaks and total peak area was observed when varying their concentration. 
The selected concentrations were 0.5 % (w/v) of DTT and 0.5 % (w/v) of SDS that also 
enabled to avoid Bradford assay interferences. 
The influence of the extraction time with the HIFU probe was studied in the range from 
0.5 to 15 min observing (see Figure 3A) an increase in total peak in the first minute. 
Moreover, different probe amplitudes were also tested (see Figure 3B) observing that a 30 









Figure 3. Variation of total area of peaks obtained by RP-HPLC with the extraction time (A) and 
with the HIFU probe extraction amplitude (B). Chromatographic conditions as in Figure 2. 
Some protein extraction protocols include a boiling step for a further protein 
denaturation that favors the extraction of most hydrophobic proteins (Wu et al., 2014). 
However, no improvement was observed in the protein extraction from peach seeds when 
this step was included. Finally, extracted proteins were precipitated with cold acetone at 
different times (0.25, 0.5, 1, 2, and 24 h) observing that a precipitation time of 15 min was 
enough for that purpose. 
Under these optimized extraction conditions, it was possible to extract 43.0 ± 3.3 g of 
protein per 100 g of dried and defatted milled seeds which constitutes an increase of 27 % 
in extracted proteins in relation to initial conditions. This protein content is similar to the 
obtained with plum (38.6 ± 2.7) and cherry (39.2 ± 5.8) seeds (González-García, García, & 
Marina, 2014; García, Endermann, González-García, & Marina, 2015).  Figure 4 also 
shows the electrophoretic separation of proteins extracted under optimized conditions 
observing a higher amount of bands than with initial extraction conditions. In all cases, 








Figure 4. DH variation (%) obtained in the digestion of peach seed proteins with Thermolysin, 
Alcalase, Flavourzyme, and Protease P vs digestion time. 
3.2. Enzymatic digestion of proteins 
In order to obtain peptides from the peach seed protein isolate previously extracted, four 
different enzymes were tried: Alcalase, Thermolysin, Flavourzyme, and Protease P. 
Enzyme selection was based on previous results obtained in literature (García et al., 2013). 
Since this is the first time that peach seed proteins are digested, a previous optimization of 
some parameters was carried out in order to obtain the highest hydrolysis degree. Studied 
parameters were: substrate concentration, digestion buffer, digestion time, and 
enzyme/substrate (E/S) ratio. Digestion temperature was that showing the maximum 
enzyme activity according to the literature: 50 °C for Alcalase, Thermolysin, and 
Flavourzyme, and 40 °C for Protease P (Esteve, Marina, & García, 2015; Ambigaipalan, 
Al-Khalifa, & Shahidi, 2015; Zhu et al., 2010; González-García et al., 2014; García et al., 
2013). 
Four different substrate concentrations were employed: 2.5, 5.0, 7.5, and 10 mg/mL. 
Based on the % DH values, optimal substrate concentrations were: 5 mg/mL for Alcalase, 
Thermolysin, and Flavourzyme and 7.5 mg/mL for Protease P. Moreover, different 
digestion buffers and pHs were tried for every enzyme: 5 mM PB (pHs 7.0, 7.5, and 8.0) 
and 5 mM borate buffer (pHs 8.5 and 9.0) were employed with Alcalase and Thermolysin 
while 5 mM ABB (pHs 5.5, 6.0, and 6.5) and 5 mM PB (pHs 7.5 and 8.0) were employed 
with Protease P. Buffer pHs were selected taking into account optimal pH ranges of every 
enzyme. The highest DH when using Alcalase and Thermolysin was observed with PB at 
pH 8.0, whereas a PB at pH 7.5 and an ABB at pH 6.5 were optimal for Protease P and 
Flavourzyme, respectively. Furthermore, E/S ratios from 0.1 to 0.7 AU/g protein were tried 
for Alcalase observing the highest DH at 0.1 AU/g protein. In the case of Thermolysin, E/S 
ratios from 0.03 to 0.4 g enzyme/g protein were tried choosing 0.1 g enzyme/g protein as 
optimum. In the case of Protease P, E/S ratios from 0.3 to 5.0 mg enzyme/g protein were 
tried being 5.0 mg enzyme/g protein the ratio yielding the highest DH. No significant 
variation in the DH was observed when varying the E/S ratio from 25 to 100 AU/g protein 
in the case of Flavourzyme. In addition, different digestion times within 30 min to 24 h 
were studied (see Figure 4). Two different phases were observed in all cases: an initial 
phase taking 3-4 h in which there was a significant increase in the DH and a second phase 
in which the DH was kept. Selected digestion times have been included in Table 1 along 
with other optimized digestion parameters and the DH obtained when using these digestion 
conditions. DH of samples ranged from 58 to 77%. Under these digestion conditions, blank 
digestions in absence of protein sample were carried out to check enzyme autodigestion. 
Results demonstrated that under the optimized digestion conditions there was no autolysis 
and that all observed peptides came from the peach seed proteins. 
The DH reached by hydrolysates depends on the enzyme ability to hydrolyze specific 
peptide bonds within the protein chain. Since all employed enzymes presented low 
specificity, high DH were obtained. These DH were similar to the previously observed for 
olive (Esteve et al., 2015) and plum (González-García et al., 2014) seeds using the same 
enzymes and slightly higher than those observed for the cherry seeds (García et al., 2015).  
3.3. Evaluation of ACE-inhibitory capacity 
Peptide extracts obtained by digestion with Alcalase, Thermolysin, Flavourzyme, and 
Protease P were submitted to an in vitro ACE-inhibitory assay in order to evaluate their 
potential antihypertensive capacity. Figure 5 shows the IC50 values obtained under optimal 
conditions with the four enzymes. Thermolysin was the enzyme yielding the highest HD 
Table 1. Optimal conditions for the digestion of peach seed proteins with different 
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c Ammonium bicarbonate buffer 
 
and also the highest ACE-inhibition capacity (IC50= 18.6 ± 0.7 µg/mL) followed by 
Alcalase and Protesase P. Flavourzyme was the enzyme that yielded the extract with the 
lowest potential despite it showed a DH higher than Protease P. Thermolysin along with 
Alcalase cleave peptide bonds close to hydrophobic amino acid residues that are very 
favorable for ACE-inhibition activity at C-terminal position (Puchalska et al., 2015). On the 
other hand, Thermolysin was also the enzyme yielding the hydrolysates with the highest 
ACE-inhibition capacity in olive (Esteve et al., 2015), plum (González-García et al., 2014), 






Figure 5. Comparison of the in vitro ACE-inhibitory capacity of peptide extracts obtained in the 
digestion of peach seed proteins with Thermolysin, Alcalase, Flavourzyme and Protease P. 
The digested extract obtained when using Thermolysin was fractionated by 
ultrafiltration obtaining fractions above 5 kDa, from 3 to 5 kDa, and below 3 kDa. Fraction 
above 5 kDa and between 5 and 3 kDa could not reach a 50% ACE inhibition while 
fraction below 3 kDa yielded an IC50 value of 16.4 ± 1.4 µg/mL.  Thus, potential 
antihypertensive peptides in the extract obtained with Thermolysin seemed to be 
concentrated in the fraction containing the shortest peptides. This behavior was expected 
since ACE inhibiting peptides show short amino acid sequences (with 2-12 amino acid 
residues) (Puchalska et al., 2015). Comparing with other fruit byproducts, peach seed 
peptides showed a higher ACE-inhibitory capacity than the observed for the fraction < 1 
kDa from the hydrolysis of apricot seed proteins with Alcalase (Zhu, Qiu, & Yu, 2010) or 
the observed for fractions < 3 kDa from the hydrolysis of olive seed proteins or cherry 
proteins with Thermolysin (Esteve et al., 2015; García et al., 2015).  
3.4. Evaluation of the resistance of potential antihypertensive peptides to simulated 
gastrointestinal digestion and ACE 
The in vivo activity of a bioactive peptide greatly depends on its capacity to reach target 
organs in an intact conformation. Gastrointestinal digestion (GID) is one of the processes 
that peptides have to resist to show their bioactivity. In order to evaluate the resistance of 
peptides in fraction below 3 kDa to GID, they were submitted to an in vitro digestion with 
pepsin (simulating stomach digestion) and pancreatin (simulating small intestine digestion) 
using conditions simulating in vivo ones. As expected, peptide concentration in the extract 
increased a 10% as a consequence of GID (initial peptide conc. = 2.24 ± 0.32 mg/mL; 
peptide conc. after GID = 2.47 ± 0.23 mg/mL). Nevertheless, there was not observed any 
significance difference in ACE-inhibitory capacity when comparing IC50 value before and 
after GID (test-t, p > 0.05): IC50 before GID = 16.4 ± 1.4 µg/mL; IC50 after GID = 17.1 ± 
1.4 µg/mL. 
Furthermore, in order to establish whether peptides present in fraction below 3 kDa 
were true ACE-inhibitors, it was also studied the resistance of peptides to ACE. 
Comparison of ACE-inhibitory capacity and concentration of peptides before and after their 
incubation with ACE enabled to observe that there were no statistically significant 
differences (test-t, p > 0.05): IC50 before ACE incubation = 17.1 ± 1.4 µg/mL; IC50 after 
ACE incubation = 17.6 ± 1.7 µg/mL. 
 
3.5. De novo identification of peptides by HPLC-MS/MS 
Peptides present in the fraction below 3 kDa obtained from the Thermolysin 
hydrolysate were next de novo sequenced using an HPLC-ESI-Q-ToF system and PEAKS 
software. Taking into account the short size of peptides and in order to assure a 
comprehensive peptide sequencing, both RP-HPLC and HILIC chromatographic modes 
were employed. Table 2 groups peptides sequence identified in this fraction before 
simulated GID along with their experimental molecular masses, ALC, and accuracy. Four 
peptides with a number of amino acids ranging from 4 to 8 were identified by both modes 
observing one common peptide (LYTPH).  
Table 2. Peptide sequence, ALC, and molecular mass of the peptides identified in the 













LYSPH 97 615.3016 HLLP 98 478.2903 
LLPGANH 97 720.3918 LLGLPLPK 96 849.5687 
LYTPH 96 629.3173 LYTPH 96 629.3173 
FNTQ 92 508.2281 LLNAK 95 557.3537 
 
Moreover, Venn Diagrams in Figure 6 compare peptides identified using RP-HPLC 
(Figure 6A) and HILIC (Figure 6B) modes before GID, after GID, and after GID and ACE 
hydrolysis. The peptides sequences that resisted both GID and ACE were LYSPH, LYTPH, 
and HLLP. These peptides had been previously observed in cherry seed hydrolysates 
(García et al., 2015). Rest of peptides in Table 2 were not observed after GID or ACE 
hydrolysis. Peptide LANGPENE and LLNDE were identified after GID but they were not 
observed before. These peptides were detected in the cherry seed hydrolysate (before GID) 
(García et al., 2015) and they probably were also in the initial hydrolysate (before GID) of 
the peach seed but they could not be probably identified because they were not properly 










Figure 6. Venn diagrams comparing identified peptides by ESI-Q-TOF using RP-HPLC separation 
(A) and HILIC separation (B), before simulated GID, after GID, and after both GID and ACE 
incubation. 
Peptides LYSPH, LYTPH, and HLLP showed common features of antihypertensive 
peptides (Vermeirssen, Van Camp, & Verstraete, 2004). Indeed, they showed short 
sequences and hydrophobic amino acid residues such as P and L/I and/or aromatic residues 
such as H and Y (Cheung, Wang, Ondetti, Sabo, & Chusman, 1980; Vermeirssen, Van 
Camp, & Verstraete, 2004; Alemán, Giménez, Pérez-Santin, Gómez-Gillén, & Montero, 
2011). Further investigations are needed to demonstrate that these peptides showing in vitro 
ACE-inhibitory capacity and resisting both GID and ACE hydrolysis can effectively reduce 




A new strategy for the revalorization of a peach byproduct based on the extraction of 
peptides with ACE-inhibitory capacity has been developed. Proteins from defatted peach 
seeds were extracted using a Tris-HCl buffer (pH 7.5) and a high intensity focused 
ultrasounds for 5 min. A protein isolate with a protein content higher than 95% (as dry 
basis and defatted) was obtained. Extracted proteins were digested with different enzymes 
showing the highest ACE-inhibitory capacity the hydrolysate obtained with Thermolysin. 
ACE-inhibitory peptides were concentrated in the fraction < 3 kDa which showed an IC50 
value of 16.4 ± 1.42 mg/mL. The combined use of RP-HPLC and HILIC chromatographic 
modes coupled to high resolution ESI-Q-ToF enabled the identification of three peptides 
(LYSPH, LYTPH, and HLLP) that resisted gastrointestinal enzymes and ACE in this 
peptide fraction. These peptides showed typical features of antihypertensive peptides and 
can be considered interesting candidates to reduce in vivo hypertension. Further 
investigations to demonstrate in vivo effect of these peptides are needed. 
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